NCT01207934View on ClinicalTrials.gov

Recombinant Human Leptin Therapy Effects on Insulin Action

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions
Type Two Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

placebo

saline placebo

DRUG

low-dose leptin

30mg per day of recombinant methionyl human (r-met hu) leptin for fourteen days

DRUG

high-dose leptin

80mg per day of recombinant methionyl human (r-met hu) leptin for fourteen days

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

Washington University School of Medicine

OTHER